185 related articles for article (PubMed ID: 10534517)
1. Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels.
van Besouw NM; van der Mast BJ; Smak Gregoor PJ; Hesse CJ; IJzermans JN; van Gelder T; Weimar W
Nephrol Dial Transplant; 1999 Nov; 14(11):2710-3. PubMed ID: 10534517
[TBL] [Abstract][Full Text] [Related]
2. Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction.
Smak Gregoor PJ; van Gelder T; van Besouw NM; van der Mast BJ; IJzermans JN; Weimar W
Transplantation; 2000 Jul; 70(1):143-8. PubMed ID: 10919591
[TBL] [Abstract][Full Text] [Related]
3. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
4. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings.
Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J
Transpl Immunol; 1997 Sep; 5(3):225-32. PubMed ID: 9402690
[TBL] [Abstract][Full Text] [Related]
5. Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients.
Gregoor PJ; de Sévaux RG; Hené RJ; Hesse CJ; Hilbrands LB; Vos P; van Gelder T; Hoitsma AJ; Weimar W
Transplantation; 1999 Nov; 68(10):1603-6. PubMed ID: 10589962
[TBL] [Abstract][Full Text] [Related]
6. Effects of azathioprine and mycophenolate mofetil-immunosuppressive regimens on the erythropoietic system of renal transplant recipients.
Khosroshahi HT; Asghari A; Estakhr R; Baiaz B; Ardalan MR; Shoja MM
Transplant Proc; 2006 Sep; 38(7):2077-9. PubMed ID: 16980004
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study.
Smak Gregoor PJ; van Gelder T; Hesse CJ; van der Mast BJ; van Besouw NM; Weimar W
Nephrol Dial Transplant; 1999 Mar; 14(3):706-8. PubMed ID: 10193823
[TBL] [Abstract][Full Text] [Related]
8. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
Merkel U; Lindner S; Vollandt R; Sperschneider H; Balogh A
Int J Clin Pharmacol Ther; 2005 Aug; 43(8):379-88. PubMed ID: 16119513
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolic acid trough levels after kidney transplantation in a cyclosporine-free protocol.
Smak Gregoor PJ; van Gelder T; van Besouw NM; van der Mast BJ; Hesse CJ; IJzermans JN; Weimar W
Transpl Int; 2000; 13 Suppl 1():S333-5. PubMed ID: 11112026
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients.
Cattaneo D; Gaspari F; Ferrari S; Stucchi N; Del Priore L; Perico N; Gotti E; Remuzzi G
Clin Transplant; 2001 Dec; 15(6):402-9. PubMed ID: 11737117
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
12. Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil.
Tedoriya T; Keogh AM; Kusano K; Savdie E; Hayward C; Spratt PM; Wilson M; Macdonald PS
J Heart Lung Transplant; 2002 Sep; 21(9):976-82. PubMed ID: 12231368
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.
Ducloux D; Motte G; Billerey C; Bresson-Vautrin C; Vautrin P; Rebibou JM; Saint-Hillier Y; Chalopin JM
Transpl Int; 2002 Sep; 15(8):387-92. PubMed ID: 12221456
[TBL] [Abstract][Full Text] [Related]
14. Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine.
Aleksic I; Baryalei M; Busch T; Pieske B; Schorn B; Strauch J; Sîrbu H; Dalichau H
Transplantation; 2000 Apr; 69(8):1586-90. PubMed ID: 10836367
[TBL] [Abstract][Full Text] [Related]
15. Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients.
Schrama YC; Joles JA; van Tol A; Boer P; Koomans HA; Hené RJ
Transplantation; 2000 Feb; 69(3):376-83. PubMed ID: 10706046
[TBL] [Abstract][Full Text] [Related]
16. Renal graft function and low-dose cyclosporine affect mycophenolic acid pharmacokinetics in kidney transplantation.
Cortinovis M; Gotti E; Pradini S; Gaspari F; Perico N
Transplantation; 2011 Sep; 92(5):550-6. PubMed ID: 21709602
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients.
Aw MM; Brown NW; Itsuka T; Gonde CE; Adams JE; Heaton ND; Tredger JM; Mieli-Vergani G; Dhawan A
Liver Transpl; 2003 Apr; 9(4):383-8. PubMed ID: 12682891
[TBL] [Abstract][Full Text] [Related]
18. Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil.
Wüthrich RP; Weinreich T; Ambühl PM; Schwarzkopf AK; Candinas D; Binswanger U
Nephrol Dial Transplant; 1999 Feb; 14(2):394-9. PubMed ID: 10069195
[TBL] [Abstract][Full Text] [Related]
19. Renal function and safety of heart transplant recipients switched to mycophenolate mofetil and low-dose cyclosporine.
Baryalei M; Zenker D; Pieske B; Tondo K; Dalichau H; Aleksic I
Transplant Proc; 2003 Jun; 35(4):1539-42. PubMed ID: 12826215
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
El Haggan W; Ficheux M; Debruyne D; Rognant N; Lobbedez T; Allard C; Coquerel A; Ryckelynck JP; Hurault de Ligny B
Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
